Envista (NYSE: NVST) recently received a number of ratings updates from brokerages and research firms:
- 2/6/2025 – Envista had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
- 2/6/2025 – Envista had its price target raised by analysts at Wells Fargo & Company from $20.00 to $21.00. They now have an “equal weight” rating on the stock.
- 2/6/2025 – Envista had its price target raised by analysts at Morgan Stanley from $19.00 to $20.00. They now have an “equal weight” rating on the stock.
- 2/3/2025 – Envista had its price target raised by analysts at Piper Sandler from $17.00 to $18.00. They now have a “neutral” rating on the stock.
- 1/23/2025 – Envista had its price target raised by analysts at Jefferies Financial Group Inc. from $20.00 to $22.00. They now have a “hold” rating on the stock.
Envista Stock Performance
NYSE NVST opened at $21.78 on Thursday. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. Envista Holdings Co. has a fifty-two week low of $15.15 and a fifty-two week high of $23.06. The business has a fifty day moving average of $20.06 and a 200-day moving average of $19.45. The stock has a market cap of $3.75 billion, a price-to-earnings ratio of -3.36, a price-to-earnings-growth ratio of 1.28 and a beta of 1.34.
Envista (NYSE:NVST – Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. As a group, analysts predict that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Read More
- Five stocks we like better than Envista
- 3 Tickers Leading a Meme Stock Revival
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is the Nikkei 225 index?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- How Technical Indicators Can Help You Find Oversold Stocks
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Envista Holdings Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista Holdings Co and related companies with MarketBeat.com's FREE daily email newsletter.